The global Nucleic Acid Isolation and Purificationmarket was valued at USD 2775.59million in 2016 and is projected to reach USD 5740.89millionby 2025, growing at a CAGR of 8.41% from 2017 to 2025.
Nucleic acid extraction and purification are mainly a part of molecular biology researches and a crucial step for down streaming processes carried out in the biopharmaceutical sector. The market for the technology is expected to grow at a high CAGR due to increased investments and support from private and public sector.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing investment in R&D Department
1.2 Growing expenditure in Healthcare
1.3 Availability of fund
1.4 Availability of efficient equipment
2. Market Restraints
2.1 High Cost of equipment
2.2 High degree of market consolidation
Market Segmentation:
1. By Product:
1.1 Kits
1.2 Reagents
1.3 Instruments
2. By Technology:
2.1 Column-Based Isolation and Purification
2.2 Reagent-Based Isolation and Purification
2.3 Magnetic Bead-Based Isolation and Purification
2.4 Other Technologies
3. By End User:
3.1 Academic and Government Research Institutes
3.2 Pharmaceutical and Biotechnology Companies
3.3 Contract Research Organizations
3.4 Hospitals and Diagnostic Centers
3.5 Other End Users
4. By Application:
4.1 Plasmid DNA Isolation and Purification
4.2 Total RNA Isolation and Purification
4.3 Blood DNA Isolation and Purification
4.4 Genomic DNA Isolation and Purification
4.5 Messenger RNA Isolation and Purification
4.6 Micro RNA Isolation and Purification
4.7 PCR Cleanup
4.8 Other Applications
5. By Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Agilent Technologies Inc.
2. Bio-Rad Laboratories, Inc.
3. Danaher Corporation
4. F. Hoffman-La Roche AG
5. General Electric Company
6. Illumina, Inc.
7. Promega Corporation
8. Qiagen N.V.
9. Sigma-Aldrich Co. LLC
10. Takara Bio, Inc.
11. Thermo Fisher Scientific, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Nucleic Acid Isolation and Purificationmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATIONMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATIONMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT:
5.1 Kits
5.2 Reagents
5.3 Instruments
6 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TECHNOLOGY:
6.1 Column-Based Isolation and Purification
6.2 Reagent-Based Isolation and Purification
6.3 Magnetic Bead-Based Isolation and Purification
6.4 Other Technologies
7 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER:
7.1 Academic and Government Research Institutes
7.2 Pharmaceutical and Biotechnology Companies
7.3 Contract Research Organizations
7.4 Hospitals and Diagnostic Centers
7.5 Other End Users
8 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION:
8.1 Plasmid DNA Isolation and Purification
8.2 Total RNA Isolation and Purification
8.3 Blood DNA Isolation and Purification
8.4 Genomic DNA Isolation and Purification
8.5 Messenger RNA Isolation and Purification
8.6 Micro RNA Isolation and Purification
8.7 PCR Cleanup
8.8 Other Applications
9 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATIONMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATIONMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Agilent Technologies Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Danaher Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 F. Hoffman-La Roche AG
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 General Electric Company
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Illumina, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Promega Corporation
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Qiagen N.V.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Sigma-Aldrich Co. LLC
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Development
11.10 Takara Bio, Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Development
11.11 Thermo Fisher Scientific, Inc.
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Development
12 Appendix
12.1 Related Reports